The Forbes Health editorial team is independent and objective. To help support our reporting work, and to continue our ability to provide this content for free to our readers, we receive compensation from the companies that advertise on the Forbes Health site. This compensation comes from two
By Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) September 9, 2022
New research reveals that a change in a single amino acid in the protein TKTL1 results in greater neuron production in the developing frontal lobe of the neocortex in modern humans compared wi
NEW YORK – A team from the Max Planck Institute of Molecular Cell Biology and Genetics and other centers in Germany has linked a modern human-specific amino acid substitution to development of the brain's frontal neocortex, leading to higher levels of a specific neural progenitor cell popula
Javascript is currently disabled in your browser. Several features of this site will not function whilst javascript is disabled.
open access to scientific and medical research
From submission to first editorial decision.
From editorial acceptance to publication.
The a
Zscaler (NASDAQ:ZS ) is a leading cybersecurity company that is securing the digital transformation of enterprises. According to one study, cloud security is forecasted to grow at a rapid 13.7% CAGR up until 2026 reaching $77 billion in market value. Zscaler is poised to spearhead this trend
The World Bank Group headquarters building in Washington, D.C. Photograph Source: Shiny Things – CC BY 2.0
When I was a graduate student in the 1970s, a professor suggested I read Michael Hudson’s Super Imperialism and do a paper on the World Bank. It was one of the bodies critic
© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
Findings have implications for patients who take supp
We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.
In a recent study published in the journal BMJ Open, researchers investigated the impact of fo
The European Commission has granted an orphan drug designation (ODD) to Viracta’s VIRX lead drug combination nanatinostat and valganciclovir (Nana-val) for the treatment of peripheral T-cell lymphoma (PTCL).
The Nana-val is being evaluated in the NAVAL-1 Phase 2 clinical trial for pat
Learn More about Sunshine Biopharma Inc. by gaining access to the latest research report.
Already a player in the oncology and antiviral spaces, Sunshine Biopharma Inc. SBFM is starting to make a name for itself in the $152 billion dietary supplement market with the launch of its scie
